1e
19
1
49
2
2
18
1b
1d
18
38
54
1d
2 29
1d
25
Robert L Giuntoli II, M.D.
78
54
Professor of Clinical Obstetrics and Gynecology
28
bd
3
70
Attending, Gynecologic Oncology, Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA
80
Director, Gynecologic Oncology, Chester County Hospital, West Chester, PA
a8
Attending, Gynecologic Oncology, Department of Obstetrics and Gynecology, Pennsylvania Hospital, Philadelphia, PA
81
Attending , Department of Surgery, Children's Hospital of Philadelphia, PA
11
Department: Obstetrics and Gynecology
4
1
b
1d
46
Contact information
82
4
3
3
3
2
4
b
1f
82
Jordan Center for Gynecologic Oncology at Penn Perelman Center for Advanced Medicine
1f 3400 Civic Center Blvd.
33 10th Floor South
Philadelphia, PA 19104
26
1f 3400 Civic Center Blvd.
33 10th Floor South
Philadelphia, PA 19104
2e
Office: 800-789-7366
30
ad
12
30
13
Education:
21 9 B.A. 14 (Biology) c
45 University of Pennsylvania, Philadelphia, PA, 1990.
21 9 M.D. c
62 University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 1994.
c
3
3
3
3
8d
Permanent link21 9 B.A. 14 (Biology) c
45 University of Pennsylvania, Philadelphia, PA, 1990.
21 9 M.D. c
62 University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 1994.
c
2 29
21
1e
1d
24
2b
29
27
23
105 Tubridy E, Gysler S, Latif NA, Ko EM, Giuntoli RL 2nd, Kim SH, Nasioudis D.: Role of lymphadenectomy for apparent early-stage low-grade serous ovarian carcinoma. Int J Gynecol Cancer 2025.
144 Mulugeta-Gordon L, Gysler S, Latif NA, Ko EM, Giuntoli RL 2nd, Kim SH, Nasioudis D.: Quality of adjuvant radiation therapy and impact on the survival of patients with lymph node-positive squamous cell carcinoma of the vulva. Int J Gynecol Cancer 2025.
160 Caruso G, Kumar A, Langstraat CL, McGree ME, Fought AJ, Harrington S, Nasioudis D, Aletti GD, Colombo N, Giuntoli RL, Cliby W.: Racial/ethnic, socioeconomic, and healthcare access disparities in achieving textbook oncologic outcome in advanced ovarian cancer. Gynecol Oncol 2025.
10e Nasioudis D, Gysler S, Latif NA, Giuntoli RL 2nd, Kim SH, Ko EM.: Incidence of lymph node metastases in patients with apparent early-stage endometrioid ovarian carcinoma. Int J Gynecol Cancer 2025.
132 Nasioudis D, Labban N, Gysler S, Ko EM, Giuntoli RL 2nd, Kim SH, Latif NA: Outcomes of Radical Hysterectomy for Early-Stage Cervical Carcinoma, with or without Prior Cervical Excision Procedure. Cancers (Basel) 16(11):2051, May 2024.
169 Nasioudis D, Gysler S, Latif NA, Giuntoli RL 2nd, Kim SH, Ko EM: Role of systematic lymphadenectomy at the time of interval debulking surgery for patients with advanced-stage epithelial ovarian carcinoma who achieved complete gross resection. Int J Gynecol Cancer 34(7):969-974, May 2024.
157 Nasioudis D, Gysler S, Latif N, Cory L, Giuntoli RL 2nd, Kim SH, Simpkins F, Martin L, Ko EM: Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions. Gynecol Oncol 180:1-5, Jan 2024.
143 Nasioudis D, Wang X, Dhillon G, Latif N, Ko EM, Giuntoli RL 2nd, Gershenson D, Fader A, Carey M, Simpkins F: Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery. 4f Int J Gynecol Cancer Page: 33(12):1906-1912, Dec 2023.
157 Nasioudis D, Arevalo O, Gysler S, Ko EM, Cory L, Kim SH, Giuntoli RL 2nd, Latif NA: Impact of delayed interval cytoreductive surgery on the survival of patients with advanced stage high-grade epithelial ovarian carcinoma. Int J Gynecol Cancer ijgc-2023-004805, Dec 2023.
2c
7
1d
1f
Selected Publications
159 Caruso G, Ainio C, Fumagalli D, Reynolds EA, Nasioudis D, Mc Gree ME, Fought AJ, Giuntoli RL, Mariani A, Cliby WA.: Textbook oncologic outcome in endometrial cancer surgery: A quality measure to improve survival and address disparities. Gynecol Oncol 200: 33-43, Jul 2025.105 Tubridy E, Gysler S, Latif NA, Ko EM, Giuntoli RL 2nd, Kim SH, Nasioudis D.: Role of lymphadenectomy for apparent early-stage low-grade serous ovarian carcinoma. Int J Gynecol Cancer 2025.
144 Mulugeta-Gordon L, Gysler S, Latif NA, Ko EM, Giuntoli RL 2nd, Kim SH, Nasioudis D.: Quality of adjuvant radiation therapy and impact on the survival of patients with lymph node-positive squamous cell carcinoma of the vulva. Int J Gynecol Cancer 2025.
160 Caruso G, Kumar A, Langstraat CL, McGree ME, Fought AJ, Harrington S, Nasioudis D, Aletti GD, Colombo N, Giuntoli RL, Cliby W.: Racial/ethnic, socioeconomic, and healthcare access disparities in achieving textbook oncologic outcome in advanced ovarian cancer. Gynecol Oncol 2025.
10e Nasioudis D, Gysler S, Latif NA, Giuntoli RL 2nd, Kim SH, Ko EM.: Incidence of lymph node metastases in patients with apparent early-stage endometrioid ovarian carcinoma. Int J Gynecol Cancer 2025.
132 Nasioudis D, Labban N, Gysler S, Ko EM, Giuntoli RL 2nd, Kim SH, Latif NA: Outcomes of Radical Hysterectomy for Early-Stage Cervical Carcinoma, with or without Prior Cervical Excision Procedure. Cancers (Basel) 16(11):2051, May 2024.
169 Nasioudis D, Gysler S, Latif NA, Giuntoli RL 2nd, Kim SH, Ko EM: Role of systematic lymphadenectomy at the time of interval debulking surgery for patients with advanced-stage epithelial ovarian carcinoma who achieved complete gross resection. Int J Gynecol Cancer 34(7):969-974, May 2024.
157 Nasioudis D, Gysler S, Latif N, Cory L, Giuntoli RL 2nd, Kim SH, Simpkins F, Martin L, Ko EM: Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions. Gynecol Oncol 180:1-5, Jan 2024.
143 Nasioudis D, Wang X, Dhillon G, Latif N, Ko EM, Giuntoli RL 2nd, Gershenson D, Fader A, Carey M, Simpkins F: Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery. 4f Int J Gynecol Cancer Page: 33(12):1906-1912, Dec 2023.
157 Nasioudis D, Arevalo O, Gysler S, Ko EM, Cory L, Kim SH, Giuntoli RL 2nd, Latif NA: Impact of delayed interval cytoreductive surgery on the survival of patients with advanced stage high-grade epithelial ovarian carcinoma. Int J Gynecol Cancer ijgc-2023-004805, Dec 2023.
2c